ADHD & Genetics: Why ADHD Runs in Families
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition characterised by developmentally inappropriate and impairing difficulties with attention regulation and/or hyperactivity and impulsivity.
Although ADHD is frequently first recognised during childhood, it should not be regarded simply as a childhood behavioural disorder. For many people, clinically important symptoms and associated impairments continue through adolescence and into adult life. The way ADHD presents can also change with age: overt motor hyperactivity may become less prominent, while difficulties with attention regulation, organisation, time management, impulsivity, internal restlessness and executive functioning may remain highly significant.
One of the most firmly established findings in ADHD research is that genetic factors make a major contribution to its development.
ADHD is Highly Heritable
ADHD runs strongly in families. Evidence from decades of family, adoption and twin studies indicates that differences in genetic liability account for a substantial proportion of the variation in ADHD traits within the population.
Across 37 twin studies, the average estimated heritability of ADHD was approximately 74%. Heritability estimates are broadly similar across childhood, adolescence and adulthood when ADHD is assessed using clinical diagnoses or multiple informants.
This figure is sometimes misunderstood.
A heritability of around 74% does not mean that 74% of an individual person's ADHD is genetic, nor does it mean that somebody has a 74% probability of inheriting ADHD from a parent. Heritability describes how much of the variation in ADHD liability across a population can statistically be attributed to genetic differences under the conditions studied.
Environmental and developmental factors remain important.
Why ADHD Often Appears Across Generations
Having a close biological relative with ADHD substantially increases a person's probability of having ADHD themselves.
This is why, during an adult ADHD assessment, it is common to hear descriptions of parents, siblings or children with similar lifelong patterns of distractibility, impulsivity, restlessness, disorganisation or emotional dysregulation — sometimes despite those relatives never having been formally assessed.
Family clustering is substantial. Earlier family studies found markedly increased rates of ADHD among siblings of people with ADHD, while adoption studies support an important genetic rather than purely shared-environmental explanation.
Very large contemporary population studies continue to demonstrate this intergenerational association. For example, a 2026 Swedish nationwide register study involving more than 1.1 million offspring found that parental ADHD was strongly associated with ADHD in children, with the association greatest when both parents had ADHD.
Importantly, however, there is no simple fixed percentage that can accurately predict whether the child of a particular parent with ADHD will develop the condition.
ADHD risk reflects the combined effects of many genetic variants together with developmental and environmental influences.
There Is No Single “ADHD Gene”
ADHD is not usually caused by a single genetic mutation.
For most people, ADHD has a polygenic architecture. This means that thousands of common genetic variants contribute very small amounts of risk, with different combinations contributing to an individual's overall genetic liability.
This is a major change from some older descriptions of ADHD genetics.
Earlier research frequently focused on individual “candidate genes”, including dopamine-related genes such as DRD4 and SLC6A3/DAT1. Although biologically interesting, these individual variants have not proved sufficiently reliable or specific to function as diagnostic markers for ADHD.
Modern ADHD genetics instead uses genome-wide association studies, or GWAS, which examine genetic variation across the entire genome in very large populations.
A landmark 2023 international GWAS involving approximately 39,000 people with ADHD and 187,000 controls identified 27 genome-wide significant ADHD risk loci and highlighted 76 potential risk genes. The findings implicated genes involved particularly in early brain development and neuronal function.
This provides much stronger evidence for ADHD as a biologically complex neurodevelopmental condition than the older search for one or two “ADHD genes”.
ADHD Genetics Goes Beyond Dopamine
Dopamine remains highly relevant to ADHD neuroscience, and dopaminergic systems are involved in motivation, reinforcement learning, attention and behavioural regulation. The effectiveness of stimulant medications also demonstrates the clinical importance of catecholamine signalling.
However, it is misleading to describe ADHD simply as a dopamine deficiency or to suggest that people with ADHD are inherently “dopamine hunters”.
The neurobiology is considerably more complex.
Current genetic research implicates multiple biological pathways, brain-development processes and neuronal systems. The 2023 ADHD GWAS identified enrichment in genes expressed during early brain development and implicated several neuronal populations, including — but not limited to — midbrain dopaminergic neurons.
ADHD therefore appears to involve altered development and regulation of distributed neural systems involved in attention, executive control, reward processing, motivation, activity regulation and behavioural inhibition, rather than a simple shortage of one neurotransmitter.
Genetic Risk Exists on a Continuum
Another important development in ADHD genetics is the recognition that there is no sharp biological boundary separating people with ADHD from everybody else.
Genetic studies support the idea that ADHD represents the clinically impairing end of continuously distributed traits such as attention regulation, impulsivity and activity level.
People throughout the general population carry varying amounts of genetic liability associated with ADHD. A clinical diagnosis becomes appropriate when the characteristic symptoms form a persistent developmental pattern and cause significant impairment in everyday functioning.
This helps explain why relatives of someone with ADHD may recognise substantial ADHD-like traits without necessarily meeting full diagnostic criteria.
ADHD Shares Some Genetic Liability With Other Conditions
ADHD does not exist genetically in isolation.
Large genomic studies show substantial overlap between genetic liability for ADHD and that associated with several other psychiatric and neurodevelopmental characteristics.
The 2023 GWAS estimated extensive sharing of ADHD-associated genetic variants with other psychiatric disorders, while subsequent research has shown that different polygenic profiles may contribute to some of the clinical variation seen among people with ADHD, including co-occurring autism and substance-use disorders.
This does not mean that ADHD, autism or another psychiatric disorder are the same condition. It indicates that some biological vulnerabilities are shared across traditional diagnostic boundaries.
Clinically, this is consistent with the relatively frequent coexistence of ADHD with autism, anxiety disorders, mood disorders, learning difficulties and substance-use disorders.
Can a Genetic Test Diagnose ADHD?
No.
At present, there is no clinically validated genetic blood test, saliva test or polygenic score that can determine whether an individual does or does not have ADHD.
ADHD remains a clinical diagnosis.
Assessment requires evidence of a persistent pattern of symptoms beginning during the developmental period, occurring in more than one setting, producing clinically significant impairment, and not being better explained by another condition.
Genetic discoveries are extremely important for understanding ADHD biology, but they are not currently diagnostic tests for individual patients.
How Common Is ADHD?
ADHD occurs throughout the world and is not confined to Western societies.
Reported prevalence varies substantially according to the diagnostic criteria used, the age of the population, whether functional impairment is required, who provides information, and whether diagnosis is established through questionnaires, interviews or clinical assessment.
Consequently, there is no single prevalence figure that applies to every study.
A major 2023 umbrella review incorporating 13 systematic reviews, 588 primary studies and more than 3.2 million children and adolescents estimated a pooled prevalence of approximately 8%, although other methodologically stringent studies have produced lower estimates.
A 2024 systematic review illustrated just how strongly methodology influences prevalence: pooled estimates ranged from approximately 1.6% in register-based studies to around 4–5% in survey and clinical epidemiological studies.
The long-established estimate of approximately 5% of children therefore remains a reasonable broad clinical shorthand, but prevalence estimates should always be interpreted in relation to how ADHD was actually measured.
Crucially, international research does not support the idea that ADHD is simply a product of Western schooling or modern lifestyles. Differences between countries are substantially influenced by methodology, diagnostic practices, awareness and access to healthcare.
Adult ADHD Is Common — and Often Missed
ADHD does not automatically disappear when someone reaches adulthood.
A major global meta-analysis estimated the prevalence of persistent adult ADHD, where childhood-onset ADHD continues into adulthood, at approximately 2.6%.
When researchers counted adults currently experiencing clinically significant ADHD symptoms irrespective of whether childhood onset could be definitively reconstructed, the estimate was considerably higher, at approximately 6.8%.
This distinction matters.
Adults may have lived with ADHD for decades without recognising it. Some develop elaborate compensatory strategies, choose occupations that suit their cognitive style, rely heavily on deadlines or external structure, or receive treatment for secondary anxiety, depression, substance misuse or burnout without the underlying ADHD being identified.
The increasing recognition of adult ADHD should therefore not automatically be interpreted as evidence that the condition itself has suddenly become more common.
ADHD Across the Lifespan
ADHD is developmentally dynamic.
Some children experience substantial reduction in symptoms as they mature. Others continue to meet full diagnostic criteria, while many fall somewhere between these two positions, experiencing fluctuating or residual symptoms and impairment.
Hyperactivity may become less externally obvious with age. An adult is less likely to be running around a classroom, but may experience:
- difficulty remaining mentally settled;
- constant internal restlessness;
- rapidly shifting thoughts;
- difficulty sustaining effort on low-interest tasks;
- poor time awareness;
- chronic procrastination;
- disorganisation;
- impulsive decision-making; or
- difficulty regulating attention according to importance rather than immediate interest.
This is one reason childhood stereotypes remain an obstacle to recognising adult ADHD.
ADHD in Girls and Women
ADHD was historically conceptualised largely from studies of boys, particularly boys displaying conspicuous hyperactive or disruptive behaviour.
Boys continue to be diagnosed with ADHD more frequently than girls during childhood. For example, the 2023 umbrella review estimated prevalence at approximately 10% in boys and 5% in girls.
However, observed diagnostic ratios do not necessarily tell us the whole story about underlying liability.
Girls may be more likely to present with predominantly inattentive symptoms, less disruptive behaviour, internalised difficulties or compensatory strategies that attract less attention at school. Referral and recognition biases can therefore contribute to delayed diagnosis.
Many women consequently reach adulthood before ADHD is recognised, sometimes following increasing demands associated with higher education, employment, parenthood or other complex responsibilities.
It would nevertheless be inaccurate simply to state that ADHD occurs equally in males and females. The biological, developmental and ascertainment reasons for the observed sex difference remain an active area of research.
Genes Are Important — But They Are Not Destiny
High heritability does not mean that outcome is predetermined.
ADHD develops through the interaction of genetic vulnerability with multiple developmental influences.
Research has identified associations between ADHD and factors including premature birth, low birth weight and some prenatal or early-life exposures. Importantly, identifying an association does not necessarily establish that the factor directly causes ADHD: genetic and family-level confounding can contribute to many apparent environmental relationships.
Sleep, stress, educational demands, relationships, substance use and the level of environmental structure can also substantially affect the expression and impact of ADHD symptoms, even when they did not cause the underlying condition.
Diet does not provide a general explanation for ADHD, and poor parenting does not cause ADHD.
Why Does Understanding the Genetics Matter?
Recognising the strong genetic contribution to ADHD has important practical consequences.
When one person is diagnosed, clinicians should be aware that other biological relatives may also have ADHD or significant ADHD traits.
A parent attending their child's assessment may recognise their own lifelong difficulties for the first time. Conversely, an adult diagnosed in their forties may subsequently recognise similar developmental patterns in their children, siblings or parents.
This can be clinically useful because identifying ADHD earlier can reduce years of misunderstanding and allow appropriate educational adjustments, psychological strategies, environmental modifications and, where indicated, medication.
It also challenges the idea that ADHD represents laziness, inadequate discipline, poor parenting or simply a failure to try hard enough.
The Bottom Line
ADHD is a highly heritable, polygenic neurodevelopmental condition.
Genetic factors account for a substantial proportion of variation in ADHD liability, with twin studies estimating heritability at approximately 74%. There is no single ADHD gene and no genetic test that currently diagnoses ADHD. Instead, large numbers of genetic variants, each exerting a very small effect, combine with developmental and environmental influences to shape an individual's likelihood of developing the condition.
Modern genomic research has now identified dozens of ADHD-associated genomic regions and is beginning to illuminate biological pathways involved in early brain development, neuronal signalling and cognitive function.
ADHD occurs across cultures, across the lifespan and in both sexes. For many people it persists well beyond childhood, although its outward presentation may change substantially with age.
Understanding the genetics of ADHD therefore does more than tell us why ADHD runs in families. It reinforces a fundamental point:
ADHD is a genuine neurodevelopmental condition arising from complex biology — not a character flaw, a parenting failure, or simply a consequence of modern life.
Although ADHD is frequently first recognised during childhood, it should not be regarded simply as a childhood behavioural disorder. For many people, clinically important symptoms and associated impairments continue through adolescence and into adult life. The way ADHD presents can also change with age: overt motor hyperactivity may become less prominent, while difficulties with attention regulation, organisation, time management, impulsivity, internal restlessness and executive functioning may remain highly significant.
One of the most firmly established findings in ADHD research is that genetic factors make a major contribution to its development.
ADHD is Highly Heritable
ADHD runs strongly in families. Evidence from decades of family, adoption and twin studies indicates that differences in genetic liability account for a substantial proportion of the variation in ADHD traits within the population.
Across 37 twin studies, the average estimated heritability of ADHD was approximately 74%. Heritability estimates are broadly similar across childhood, adolescence and adulthood when ADHD is assessed using clinical diagnoses or multiple informants.
This figure is sometimes misunderstood.
A heritability of around 74% does not mean that 74% of an individual person's ADHD is genetic, nor does it mean that somebody has a 74% probability of inheriting ADHD from a parent. Heritability describes how much of the variation in ADHD liability across a population can statistically be attributed to genetic differences under the conditions studied.
Environmental and developmental factors remain important.
Why ADHD Often Appears Across Generations
Having a close biological relative with ADHD substantially increases a person's probability of having ADHD themselves.
This is why, during an adult ADHD assessment, it is common to hear descriptions of parents, siblings or children with similar lifelong patterns of distractibility, impulsivity, restlessness, disorganisation or emotional dysregulation — sometimes despite those relatives never having been formally assessed.
Family clustering is substantial. Earlier family studies found markedly increased rates of ADHD among siblings of people with ADHD, while adoption studies support an important genetic rather than purely shared-environmental explanation.
Very large contemporary population studies continue to demonstrate this intergenerational association. For example, a 2026 Swedish nationwide register study involving more than 1.1 million offspring found that parental ADHD was strongly associated with ADHD in children, with the association greatest when both parents had ADHD.
Importantly, however, there is no simple fixed percentage that can accurately predict whether the child of a particular parent with ADHD will develop the condition.
ADHD risk reflects the combined effects of many genetic variants together with developmental and environmental influences.
There Is No Single “ADHD Gene”
ADHD is not usually caused by a single genetic mutation.
For most people, ADHD has a polygenic architecture. This means that thousands of common genetic variants contribute very small amounts of risk, with different combinations contributing to an individual's overall genetic liability.
This is a major change from some older descriptions of ADHD genetics.
Earlier research frequently focused on individual “candidate genes”, including dopamine-related genes such as DRD4 and SLC6A3/DAT1. Although biologically interesting, these individual variants have not proved sufficiently reliable or specific to function as diagnostic markers for ADHD.
Modern ADHD genetics instead uses genome-wide association studies, or GWAS, which examine genetic variation across the entire genome in very large populations.
A landmark 2023 international GWAS involving approximately 39,000 people with ADHD and 187,000 controls identified 27 genome-wide significant ADHD risk loci and highlighted 76 potential risk genes. The findings implicated genes involved particularly in early brain development and neuronal function.
This provides much stronger evidence for ADHD as a biologically complex neurodevelopmental condition than the older search for one or two “ADHD genes”.
ADHD Genetics Goes Beyond Dopamine
Dopamine remains highly relevant to ADHD neuroscience, and dopaminergic systems are involved in motivation, reinforcement learning, attention and behavioural regulation. The effectiveness of stimulant medications also demonstrates the clinical importance of catecholamine signalling.
However, it is misleading to describe ADHD simply as a dopamine deficiency or to suggest that people with ADHD are inherently “dopamine hunters”.
The neurobiology is considerably more complex.
Current genetic research implicates multiple biological pathways, brain-development processes and neuronal systems. The 2023 ADHD GWAS identified enrichment in genes expressed during early brain development and implicated several neuronal populations, including — but not limited to — midbrain dopaminergic neurons.
ADHD therefore appears to involve altered development and regulation of distributed neural systems involved in attention, executive control, reward processing, motivation, activity regulation and behavioural inhibition, rather than a simple shortage of one neurotransmitter.
Genetic Risk Exists on a Continuum
Another important development in ADHD genetics is the recognition that there is no sharp biological boundary separating people with ADHD from everybody else.
Genetic studies support the idea that ADHD represents the clinically impairing end of continuously distributed traits such as attention regulation, impulsivity and activity level.
People throughout the general population carry varying amounts of genetic liability associated with ADHD. A clinical diagnosis becomes appropriate when the characteristic symptoms form a persistent developmental pattern and cause significant impairment in everyday functioning.
This helps explain why relatives of someone with ADHD may recognise substantial ADHD-like traits without necessarily meeting full diagnostic criteria.
ADHD Shares Some Genetic Liability With Other Conditions
ADHD does not exist genetically in isolation.
Large genomic studies show substantial overlap between genetic liability for ADHD and that associated with several other psychiatric and neurodevelopmental characteristics.
The 2023 GWAS estimated extensive sharing of ADHD-associated genetic variants with other psychiatric disorders, while subsequent research has shown that different polygenic profiles may contribute to some of the clinical variation seen among people with ADHD, including co-occurring autism and substance-use disorders.
This does not mean that ADHD, autism or another psychiatric disorder are the same condition. It indicates that some biological vulnerabilities are shared across traditional diagnostic boundaries.
Clinically, this is consistent with the relatively frequent coexistence of ADHD with autism, anxiety disorders, mood disorders, learning difficulties and substance-use disorders.
Can a Genetic Test Diagnose ADHD?
No.
At present, there is no clinically validated genetic blood test, saliva test or polygenic score that can determine whether an individual does or does not have ADHD.
ADHD remains a clinical diagnosis.
Assessment requires evidence of a persistent pattern of symptoms beginning during the developmental period, occurring in more than one setting, producing clinically significant impairment, and not being better explained by another condition.
Genetic discoveries are extremely important for understanding ADHD biology, but they are not currently diagnostic tests for individual patients.
How Common Is ADHD?
ADHD occurs throughout the world and is not confined to Western societies.
Reported prevalence varies substantially according to the diagnostic criteria used, the age of the population, whether functional impairment is required, who provides information, and whether diagnosis is established through questionnaires, interviews or clinical assessment.
Consequently, there is no single prevalence figure that applies to every study.
A major 2023 umbrella review incorporating 13 systematic reviews, 588 primary studies and more than 3.2 million children and adolescents estimated a pooled prevalence of approximately 8%, although other methodologically stringent studies have produced lower estimates.
A 2024 systematic review illustrated just how strongly methodology influences prevalence: pooled estimates ranged from approximately 1.6% in register-based studies to around 4–5% in survey and clinical epidemiological studies.
The long-established estimate of approximately 5% of children therefore remains a reasonable broad clinical shorthand, but prevalence estimates should always be interpreted in relation to how ADHD was actually measured.
Crucially, international research does not support the idea that ADHD is simply a product of Western schooling or modern lifestyles. Differences between countries are substantially influenced by methodology, diagnostic practices, awareness and access to healthcare.
Adult ADHD Is Common — and Often Missed
ADHD does not automatically disappear when someone reaches adulthood.
A major global meta-analysis estimated the prevalence of persistent adult ADHD, where childhood-onset ADHD continues into adulthood, at approximately 2.6%.
When researchers counted adults currently experiencing clinically significant ADHD symptoms irrespective of whether childhood onset could be definitively reconstructed, the estimate was considerably higher, at approximately 6.8%.
This distinction matters.
Adults may have lived with ADHD for decades without recognising it. Some develop elaborate compensatory strategies, choose occupations that suit their cognitive style, rely heavily on deadlines or external structure, or receive treatment for secondary anxiety, depression, substance misuse or burnout without the underlying ADHD being identified.
The increasing recognition of adult ADHD should therefore not automatically be interpreted as evidence that the condition itself has suddenly become more common.
ADHD Across the Lifespan
ADHD is developmentally dynamic.
Some children experience substantial reduction in symptoms as they mature. Others continue to meet full diagnostic criteria, while many fall somewhere between these two positions, experiencing fluctuating or residual symptoms and impairment.
Hyperactivity may become less externally obvious with age. An adult is less likely to be running around a classroom, but may experience:
- difficulty remaining mentally settled;
- constant internal restlessness;
- rapidly shifting thoughts;
- difficulty sustaining effort on low-interest tasks;
- poor time awareness;
- chronic procrastination;
- disorganisation;
- impulsive decision-making; or
- difficulty regulating attention according to importance rather than immediate interest.
This is one reason childhood stereotypes remain an obstacle to recognising adult ADHD.
ADHD in Girls and Women
ADHD was historically conceptualised largely from studies of boys, particularly boys displaying conspicuous hyperactive or disruptive behaviour.
Boys continue to be diagnosed with ADHD more frequently than girls during childhood. For example, the 2023 umbrella review estimated prevalence at approximately 10% in boys and 5% in girls.
However, observed diagnostic ratios do not necessarily tell us the whole story about underlying liability.
Girls may be more likely to present with predominantly inattentive symptoms, less disruptive behaviour, internalised difficulties or compensatory strategies that attract less attention at school. Referral and recognition biases can therefore contribute to delayed diagnosis.
Many women consequently reach adulthood before ADHD is recognised, sometimes following increasing demands associated with higher education, employment, parenthood or other complex responsibilities.
It would nevertheless be inaccurate simply to state that ADHD occurs equally in males and females. The biological, developmental and ascertainment reasons for the observed sex difference remain an active area of research.
Genes Are Important — But They Are Not Destiny
High heritability does not mean that outcome is predetermined.
ADHD develops through the interaction of genetic vulnerability with multiple developmental influences.
Research has identified associations between ADHD and factors including premature birth, low birth weight and some prenatal or early-life exposures. Importantly, identifying an association does not necessarily establish that the factor directly causes ADHD: genetic and family-level confounding can contribute to many apparent environmental relationships.
Sleep, stress, educational demands, relationships, substance use and the level of environmental structure can also substantially affect the expression and impact of ADHD symptoms, even when they did not cause the underlying condition.
Diet does not provide a general explanation for ADHD, and poor parenting does not cause ADHD.
Why Does Understanding the Genetics Matter?
Recognising the strong genetic contribution to ADHD has important practical consequences.
When one person is diagnosed, clinicians should be aware that other biological relatives may also have ADHD or significant ADHD traits.
A parent attending their child's assessment may recognise their own lifelong difficulties for the first time. Conversely, an adult diagnosed in their forties may subsequently recognise similar developmental patterns in their children, siblings or parents.
This can be clinically useful because identifying ADHD earlier can reduce years of misunderstanding and allow appropriate educational adjustments, psychological strategies, environmental modifications and, where indicated, medication.
It also challenges the idea that ADHD represents laziness, inadequate discipline, poor parenting or simply a failure to try hard enough.
The Bottom Line
ADHD is a highly heritable, polygenic neurodevelopmental condition.
Genetic factors account for a substantial proportion of variation in ADHD liability, with twin studies estimating heritability at approximately 74%. There is no single ADHD gene and no genetic test that currently diagnoses ADHD. Instead, large numbers of genetic variants, each exerting a very small effect, combine with developmental and environmental influences to shape an individual's likelihood of developing the condition.
Modern genomic research has now identified dozens of ADHD-associated genomic regions and is beginning to illuminate biological pathways involved in early brain development, neuronal signalling and cognitive function.
ADHD occurs across cultures, across the lifespan and in both sexes. For many people it persists well beyond childhood, although its outward presentation may change substantially with age.
Understanding the genetics of ADHD therefore does more than tell us why ADHD runs in families. It reinforces a fundamental point:
ADHD is a genuine neurodevelopmental condition arising from complex biology — not a character flaw, a parenting failure, or simply a consequence of modern life.